Estech's AF (atrial fibrillation) ablation tools:
This article was originally published in Clinica
Executive Summary
The US FDA has given Estech 510(k) clearance to sell its Cobra line of products for the surgical treatment of atrial fibrillation (AF). The tools, which were also recently cleared for sale in Europe, comprise the Cobra Adhere radiofrequency ablation system and the Cobra bipolar pacing probe. The Adhere device is used to make lesions on the heart to block the electrical impulses that cause AF. The pacing probe provides a means for immediately evaluating the effectiveness of AF treatment procedures. According to the Danville, California firm, the Cobra technology is unique in that it uses an "intelligent temperature-based" system that provides both optimal and reproducible results by regulating the RF energy. "Other systems offered by AtriCure, Medtronic and Guidant do not have this advanced energy regulation technology," the company claimed.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.